All HHS Contracts — March 07, 2026

$589M obligation with $442M outlayed signals strong cash flow delivery; potential $286M options boost total to $876M.

Firm fixed-price structure exposes SERCO to cost overruns; 81 subawards ($112M) create dependency risks; long horizon to 2028 adds uncertainty.

$286M unobligated options and potential 18-month extension to Jan 2028 offer SERCO revenue upside.

Full period value funneled into one $589M CMS IT contract for Medicare/Medicaid eligibility, awarded via open competition to non-SMB.

{"entity"=>"SERCO INC", "reason"=>"Dominates HHS stream with 100% value concentration; $286M options pivotal for growth.", "trigger"=>"Option funding or extension announcement"}

{"entity"=>"CMS IT Spending", "reason"=>"Single-contract focus signals potential for follow-ons in eligibility systems.", "trigger"=>"New solicitations under NAICS 541512"}